Related by context. All words. (Click for frequent words.) 60 cancerdefine 60 breast cancer metastasis 59 post surgical adhesions 59 reperfusion injury 58 immunopathology 58 antibody mediated 57 proliferative disorders 57 GSK3 57 EBV infection 57 chitinase 57 artemisinin resistance 56 helminths 56 CMV infections 56 allograft rejection 56 Helicobacter pylori H. pylori 56 angiogenesis inhibition 56 fibrogenesis 55 deacetylase inhibitors 55 biologic pathways 55 TGF beta signaling 55 Candida infection 55 anti angiogenic drugs 55 Helicobacter 55 Alzheimer Disease AD 55 hedgehog pathway 55 AA amyloidosis 55 chemoresistance 55 colorectal tumors 55 vivax malaria 55 leukotriene pathway 55 CVD cardiovascular disease 55 antiangiogenic 55 organ transplant rejection 54 glioblastoma tumor 54 liver fibrosis 54 epigenetic mechanisms 54 mitochondrial toxicity 54 antitumor effect 54 cardiometabolic disorders 54 hedgehog signaling 54 metastatic cancers 54 respiratory viral infections 54 protein misfolding diseases 54 plasma kallikrein 54 CMV disease 54 idiopathic pulmonary 54 underlying molecular mechanisms 54 leukaemic stem cells 54 Th2 immune 54 atopic disease 54 mitochondrial decay 54 Immunosuppressive drugs 54 retroviral infection 53 ricin intoxication 53 type 1diabetes 53 chromosome aberrations 53 antimetastatic 53 Treg cell 53 acute GVHD 53 intracellular bacteria 53 yeast overgrowth 53 intracellular pathogens 53 endocrine tumors 53 inhibiting mTOR 53 hepatic toxicity 53 diseases afflicting 53 mucosal immunity 53 breast CSCs 53 imatinib resistance 53 renal fibrosis 53 motor neuron degeneration 53 suppressor cells 53 muscular dystrophies 53 malarial infection 53 inhibiting tumor 53 immune modulator 53 allergic inflammation 53 mutant huntingtin protein 53 VEGF receptor 53 hydatid disease 53 digestive tract cancers 53 gastric adenocarcinoma 53 Ebola virus infection 53 TNFa 52 H pylori 52 diabetic kidney 52 swine dysentery 52 systemic scleroderma 52 delayed CINV 52 lipid synthesis 52 Cryptococcus neoformans 52 neuroinflammation 52 prostaglandin synthesis 52 nasopharyngeal carcinoma 52 adenovirus infections 52 prostate carcinogenesis 52 VHL gene 52 CBLC# 52 ACV1 52 molecular abnormalities 52 synovial cells 52 lung fibrosis 52 invasive candidiasis 52 engineered RAP peptides 52 Scorpion venom 52 T. cruzi 52 Candida infections 52 ADPKD 52 disease CJD 52 herpes viruses 52 sortilin 52 neural degeneration 52 riociguat 52 autoimmune reactions 52 urothelial cancer 52 Ets2 52 bryostatin 52 cardiac fibrosis 52 periodontal infection 52 precancerous colon polyps 52 Bacterial infection 52 immunosuppressive therapies 52 Idiopathic Thrombocytopenic Purpura ITP 52 γδ T cells 52 malignant growths 52 SSc 52 Pseudomonas aeruginosa infections 52 NF kB signaling 52 EGF receptor 52 Disease GVHD 52 multidrug resistance 52 peroxisome 52 rituximab Rituxan 52 EGFR pathway 52 non hodgkin lymphoma 52 staphylococcal infections 52 sirtuin activators 52 malignant transformation 52 antitumor immune 52 ASPIRE HIGHER 52 kidney urologic 52 Duchenne muscular dystrophy DMD 52 ischemia reperfusion injury 51 adenovirus infection 51 anticancer therapies 51 inhibit metastasis 51 HCV infection 51 velafermin 51 mutated KRAS gene 51 hypoxic tumors 51 snail fever 51 mycosis 51 tumor suppressor protein 51 antibiotic resistant bacterial infections 51 Host Disease GvHD 51 lupus nephritis 51 neurotrophic 51 cellular pathways 51 gastric cancers 51 statins cholesterol lowering 51 membranous nephropathy 51 urinary tract infections UTIs 51 vessel constriction 51 monogenic 51 colon tumors 51 malaria parasite Plasmodium falciparum 51 parasite Leishmania 51 neovascularisation 51 H. pylori eradication 51 immuno modulatory 51 chronic viral infections 51 tumor metastasis 51 hematopoietic cells 51 cytotoxic effects 51 APOL1 51 EGFR therapies 51 OHR/AVR# 51 HCV replication 51 periodontal tissues 51 incidentalomas 51 postoperative atrial fibrillation 51 ADAMTS# 51 pulmonary fungal infections 51 Helicobacter pylori infection 51 pre cancerous growths 51 Schistosomiasis 51 oncogenesis 51 gastrointestinal GI cancers 51 Graft Versus Host 51 reflux disease 51 iron overload 51 carcinoid cancer 51 antiangiogenesis 51 HCV infections 51 Wnt signaling pathway 51 serine proteases 51 fungal pathogen 51 Strep infections 51 neuropsychiatric diseases 51 druggable targets 51 Merkel Cell Carcinoma 51 viral pathogenesis 51 GVHD 51 kidney fibrosis 51 Gamma interferon 51 Autoimmune diseases 51 haematopoietic 51 EGF receptors 51 overactivation 51 disease GVHD 51 antitumour 51 HDAC3 51 P. aeruginosa infections 51 osteopontin OPN 50 MYCN amplification 50 metastatic malignant melanoma 50 JAK3 50 adenosine A2A receptor 50 flavopiridol 50 immunoregulation 50 #ß HSD1 50 neuroendocrine cancers 50 CXCR7 50 rotaviruses 50 nerve degeneration 50 fibrocytes 50 primary hyperparathyroidism 50 Trypanosoma 50 vascular abnormalities 50 malignant pleural mesothelioma 50 nonhuman primate model 50 fibrotic disease 50 S. aureus bacteremia 50 molecular underpinnings 50 uPA 50 DFMO 50 PROCHYMAL 50 environmental toxicants 50 Borrelia 50 Lowering cholesterol 50 disease 50 antibody mediated rejection 50 molecular determinants 50 oral leukoplakia 50 fungal organisms 50 immune suppressing 50 H. pylori infection 50 neuroendocrine tumors 50 Six3 50 PTLD 50 Squalamine 50 thrombotic complications 50 apoptosis induced 50 molecularly targeted 50 prodynorphin 50 G6PD deficiency 50 CB2 receptor 50 HuLuc# 50 micronutrient deficiency 50 inhibiting enzymes 50 schistosomiasis 50 antibiotic resistant superbugs 50 Dasatinib 50 Genetic variants 50 Gastric cancer 50 viral bacterial 50 intestinal polyps 50 Cyclosporine 50 skeletal metastases 50 aP2 50 inherited retinal degeneration 50 brain tumor glioblastoma multiforme 50 disease NAFLD 50 parasitic worm infections 50 cAMP signaling 50 necrotizing pneumonia 50 Epstein Barr virus EBV 50 N Myc 50 nonalcoholic steatohepatitis NASH 50 MitoQ 50 podocytes 50 lymphoid organs 50 secondary hyperparathyroidism 50 bone metastasis 50 gastric lymphoma 50 Akt3 50 antiobesity 50 small strongyles 50 mtDNA mutations 50 neurite outgrowth 50 fungus Fusarium 50 erlotinib Tarceva 50 Trichomonas 50 hypophosphatasia 50 oncomodulin 50 VZV 50 Glioblastoma Multiforme 50 GPR# receptor [002] 50 genetic determinants 50 colorectal carcinoma 50 infectious prion proteins 50 choriocarcinoma 50 aneuploid cells 50 prostate cancer CaP 50 cytomegalovirus CMV 50 microbial pathogens 50 P#X# 50 TTR gene 50 Staphylococcus aureus infections 50 reemerging infectious diseases 50 amyloid deposits 50 COX enzymes 50 parasitic flatworms 50 Kenneth Kinzler 50 cellular senescence 50 TLE3 49 thoracic aortic disease 49 herpes infection 49 triterpenoids 49 parasitic worms 49 GIST tumors 49 tumor metastases 49 neovascular diseases 49 biochemical mechanisms 49 anti apoptotic proteins 49 protein misfolding 49 pancreatic cancers 49 immuno inflammatory 49 hormone ghrelin 49 paratuberculosis 49 transplantation HCT 49 epigenetic changes 49 EGFR inhibitors 49 mitochondrial disorders 49 amyloid toxicity 49 antiangiogenic therapy 49 angiosarcoma 49 infantile hemangioma 49 unresectable tumors 49 rheumatic diseases 49 nonmelanoma skin cancers 49 basiliximab 49 resolvins 49 mitochondrial mutations 49 transplanted bone marrow 49 recurrent glioblastoma multiforme GBM 49 heart arrhythmias 49 Lyme arthritis 49 hepatitis C infection 49 cancer 49 resistant pathogens 49 malignant pancreatic 49 therapeutic monoclonal antibody 49 potent inhibitors 49 acute promyelocytic leukemia APL 49 investigational monoclonal antibody 49 diseases 49 melanoma tumors 49 viral infections 49 pemphigus 49 underlying vasculopathy 49 protozoan parasites 49 neuro degenerative diseases 49 beta defensins 49 diseases NTDs 49 platelet deficiency 49 lysosomal diseases 49 molecularly targeted therapies 49 Gleevec imatinib 49 arachidonic acid metabolism 49 liver metastasis 49 Plasmodium falciparum malaria 49 herpes virus infections 49 ovarian tumors 49 systemic inflammation 49 parasitemia 49 refractory gout 49 panobinostat 49 immunosuppressive regimens 49 Entamoeba histolytica 49 intracranial hemorrhage ICH 49 beta1 integrin 49 Genetic variation 49 prostate cancer PCa 49 parthenolide 49 pancreatic adenocarcinoma 49 artery clogging plaque 49 fibrotic diseases 49 associated lymphoid tissue 49 immunological diseases 49 c myc gene 49 branching morphogenesis 49 NF kB pathway 49 systemic toxicity 49 bone morphogenetic proteins BMPs 49 metastatic lymph nodes 49 vivo validation 49 IDH1 mutations 49 cranial irradiation 49 oesophageal adenocarcinoma 49 urokinase plasminogen activator 49 TAT2 49 tissue fibrosis 49 destroy cancerous cells 49 leptin resistance 49 Plasmodium parasite 49 lapatinib Tykerb 49 T#I mutant 49 polyglutamine diseases 49 pyrethroid resistance 49 nifurtimox 49 GRK2 49 CDDO Im 49 osteoclast activity 49 cyclosporin 49 neuronal degeneration 49 atherogenesis 49 zoonotic pathogens 49 premenstrual syndrome PMS 49 Candida overgrowth 49 potent antioxidant properties 49 Alzheimers disease 49 Notch1 49 TGF β 49 pancreatic islet 49 cholesterol metabolism 49 Glioblastoma multiforme 49 dietary interventions 49 prion diseases 49 bowel cancers 49 atherosclerotic lesions 49 vaginal yeast infections 49 Glioblastoma Multiforme GBM 49 venous malformations 49 herpesviruses 49 stem cell differentiation 49 biologic plausibility 49 immunoregulatory 49 hematopoietic malignancies 49 broadly neutralizing antibody 49 metastatic tumors 49 HBV replication 49 cancers 49 ABL kinase 49 cisplatin resistant 49 anticancer therapy 49 activin 49 Therapeutic antibodies 49 molecular pathways 49 diabetic retinopathy DR 49 aortic dissections 49 Genetic variations 49 epithelial tumors 49 TTR amyloidosis 49 rheumatic disease 49 Metastatic melanoma 49 C. pneumoniae 49 degenerative neurological diseases 49 Glioblastoma multiforme GBM 49 M.tb 49 Symadex 49 Candida species 49 autoreactive T cells 49 neovascularization 49 nanobacteria 48 lichen planus 48 TNF α 48 hematologic disorders 48 DHFR 48 recurrent venous thromboembolism 48 gastro intestinal diseases 48 malayi 48 metabolic alterations 48 acid secretion 48 tumor vascularization 48 Chronic lymphocytic leukemia 48 hormonal disorder 48 metastatic neuroendocrine tumors 48 squamous cell lung cancer 48 neuroblastoma tumors 48 anterior uveitis 48 carcinoid 48 hepatocellular carcinoma 48 p# MAPK 48 Epstein Barr virus 48 cardiolipin 48 P. vivax 48 CMV reactivation 48 HDAC6 48 esophageal squamous cell carcinoma 48 Vitamin D insufficiency 48 malarial parasites 48 protozoal 48 cell signaling pathway 48 premalignant 48 malignancy 48 sCD# 48 Hepatitis C virus 48 virulent pathogen 48 superficial bladder cancer 48 PCNSL 48 Th1 cells 48 Wnts 48 oral JAK1 48 rhinovirus infection 48 bacterium Bacillus anthracis 48 systemic fungal infections 48 fungal meningitis 48 Treg cells 48 BCL#A 48 CMV infection 48 gefitinib Iressa 48 immunological mechanisms 48 SCD1 48 interleukin 1beta 48 pre cancerous cells 48 S. aureus infections 48 mTOR inhibition 48 vascular thrombosis 48 tumor microenvironment 48 adult neurogenesis 48 metabolic dysfunction 48 alkylating agent 48 mTOR inhibitors 48 UVB induced 48 atherosclerosis narrowing 48 idiopathic pulmonary fibrosis IPF 48 immunosuppressive medications 48 pancreatic carcinoma 48 Hepatocellular Carcinoma HCC 48 pulmonary hypertension PH 48 Malignant tumors 48 acute promyelocytic leukemia 48 idarubicin 48 bacteria Streptococcus pneumoniae 48 viral hemorrhagic fevers 48 Cerebral malaria 48 Prion diseases 48 sickle cell hemoglobin 48 WT1 48 staphylococcal infection 48 untreatable diseases 48 renal toxicity 48 cytotoxic therapies 48 chemosensitivity 48 gastrointestinal cancers 48 adult mesenchymal stem 48 BMP4 48 leukocyte recruitment 48 Graft versus 48 familial adenomatous polyposis 48 transdifferentiation 48 Epratuzumab 48 idiopathic thrombocytopenic purpura ITP 48 bacterial virulence 48 adipogenesis 48 biothreats 48 secondary bacterial infections 48 Dr. Victor Velculescu 48 venous blood clots 48 innate immunity 48 neuro degenerative disorders 48 GCN2 48 diagnostic biomarker 48 primary cilia 48 PGRN 48 dietary antioxidants 48 Cancer cachexia 48 NPHP 48 resistant superbugs 48 cardiovascular disease hypertension 48 Bryostatin 48 pneumocystis 48 Notch pathway 48 premalignant lesions 48 genetic polymorphism 48 pneumococcal strains 48 pathogenetic 48 antibiotic resistant infections 48 transplanted islets 48 nonalcoholic steatohepatitis 48 antiviral compounds 48 lipid mediators 48 diabetic nephropathy 48 proto oncogene 48 Pancreatic 48 nephritis 48 H. pylori bacteria 48 Clostridium difficile infections 48 Chronic inflammation 48 noncancerous tumors 48 degenerative retinal diseases 48 poxviruses 48 synovial sarcoma 48 bovine mastitis 48 bacterial infections 48 hepatitis C virus 48 proliferative diabetic retinopathy 48 Bcr Abl mutations 48 angiogenesis inhibitor 48 medulloblastomas 48 chronic granulomatous disease 48 esophageal adenocarcinoma 48 biofilm infections 48 ductal adenocarcinoma 48 fungal pathogens 48 neutralizing antibody 48 mitochondrial fusion 48 virulence genes 48 parasitic nematode 48 MMP inhibitors 48 bacterial antibiotic resistance 48 ximelagatran 48 gastrointestinal stromal tumor 48 mitochondrial fragmentation 48 monoclonal antibody therapeutics 47 serous ovarian cancer 47 tumor recurrence 47 heterozygous FH 47 prostate tumors 47 KRAS mutational status 47 Cholangiocarcinoma 47 proteoglycan 47 DNA methylation patterns 47 Pseudomonas aeruginosa bacterium 47 lung tumors 47 corticosteroid therapy 47 cutaneous melanoma 47 thymosin beta 4 47 metabolic disturbances 47 SIRT1 gene 47 Lpathomab 47 Malignant glioma 47 metastatic colorectal 47 immunosuppressant drug 47 Herpes virus 47 insulin sensitizers 47 pancreatic lung 47 tumors 47 aortic rupture 47 candida infections 47 neuroblastoma tumor 47 human African trypanosomiasis 47 signaling cascades 47 cathepsin K 47 cytomegalovirus 47 atherosclerosis hardening 47 stellate cells 47 Burkholderia pseudomallei 47 myelofibrosis polycythemia vera 47 steroid refractory 47 blood clotting disorders 47 mammary tumors 47 Lateral Sclerosis ALS 47 degenerative disorders 47 Velcade bortezomib 47 opportunistic fungal infections 47 myelin repair 47 eosinophilic inflammation 47 ileitis 47 olmesartan 47 renal transplantation 47 parasite Plasmodium falciparum 47 secretory diarrhea 47 Malignant Melanoma 47 pathogen interactions 47 PPARg 47 osteoclast 47 EGFRIs 47 Neurodegenerative diseases 47 Darapladib 47 thalidomide Thalomid 47 testicular cancers 47 RNA silencing 47 tenascin C 47 STAT4 47 skeletal muscle weakness 47 tau tangles 47 discoid lupus 47 pathogenic viruses 47 bacterium Staphylococcus aureus 47 adaptive immunity 47 canakinumab 47 leukemia ALL 47 diagnose Alzheimer disease 47 CDK inhibitors 47 pneumococcus bacteria 47 diabetic cardiomyopathy 47 pleural mesothelioma 47 whipworm 47 endometrial hyperplasia 47 renal allograft 47 tumor regrowth 47 EGFR receptor 47 leukoencephalopathy 47 menin 47 PAOD 47 torsade de pointes 47 cirrhosis liver failure 47 anthracycline chemotherapy 47 diabetic microvascular complications 47 myopathy rhabdomyolysis 47 tyrosine kinase inhibitor 47 glioma cells 47 infective endocarditis IE 47 BRAF V#E 47 proliferative diseases 47 visilizumab 47 transgene expression 47 MYH9 47 pre malignant lesions 47 dis eases 47 parasitic infections 47 neural disorders 47 systemic lupus erythematosus 47 abiraterone 47 epigenomics 47 renal carcinoma 47 S. maltophilia 47 gallstone formation 47 tamoxifen metabolism 47 liver scarring 47 acute lymphoblastic 47 nucleoside analogues 47 gastric cardia 47 Paul Sanberg 47 organ rejection 47 periodontitis 47 hepatic arterial 47 Sertoli cell 47 Huntingtons disease 47 fat hormone leptin 47 RNAi therapeutic targeting 47 GPR# [002] 47 VEGF inhibitors 47 PARP inhibitors 47 El Deiry 47 candida overgrowth 47 antioxidant enzymes 47 Wnt pathway 47 Dr. Kolls 47 hemorrhagic fever viruses 47 pulmonary metastasis 47 excitotoxicity 47 vascular dysfunction 47 TGF beta1 47 trypanosomiasis 47 choroidal melanoma 47 Neurological disorders 47 anaplastic 47 Glioma 47 ciliated cells 47 NKT cells 47 cell signaling pathways 47 nephrotoxicity 47 erythropoietic 47 Sarcopenia 47 radiation therapy SBRT 47 molecular biomarkers 47 recurrent glioblastoma multiforme 47 amyloidosis 47 MAP kinase pathway 47 prostate cancers 47 lymphoproliferative disorder 47 USP# 47 nephropathy 47 lipid metabolites 47 motor neuron diseases 47 immune suppression 47 P. vivax malaria 47 cholangiocarcinoma 47 CXCR4 receptor 47 hardened arteries 47 elevated CRP 47 P. falciparum parasites 47 bladder tumors 47 Dr. Rafii 47 bacterial respiratory infections 47 Antibiotic resistant bacteria 47 pancreatic islet cell 47 Periodontal disease 47 chlamydial infections 47 cranial radiation 47 PARP inhibition 47 acute leukemia AML 47 artherosclerosis 47 statin medications 47 ADAM# 47 myotonic muscular dystrophy 47 Leber Congenital Amaurosis LCA 47 tumoral 47 proteasome inhibitors 47 pediatric malignancies 47 diseases fat malabsorption 47 dengue viruses 47 insertional mutagenesis 47 cystic fibrosis chronic pancreatitis 47 immunosuppressed patients 47 spinal muscular atrophy SMA 47 coagulation cascade 47 proteasome inhibitor 47 PEDF 47 parasite 47 psoriatic 46 postoperative pulmonary 46 hereditary predisposition 46 O. volvulus 46 lymphomas leukemias 46 cardiac progenitor cells 46 mycophenolate mofetil 46 oncolytic virus 46 immune suppressants 46 Hotamisligil 46 lung metastasis 46 protein homeostasis 46 pharmacological therapies 46 sclerostin 46 hypovitaminosis D 46 Idiopathic Pulmonary Fibrosis 46 neuronal nicotinic receptors NNRs 46 pheochromocytoma 46 myocyte 46 inhibit viral replication 46 chlamydial infection 46 caner 46 periodontal diseases 46 dyskeratosis congenita 46 doxorubicin Adriamycin 46 mycosis fungoides 46 small molecule activators 46 parasitic nematodes 46 Severe Primary IGFD 46 podocyte 46 haematological cancers 46 LRP1 46 atherosclerotic disease 46 deferiprone 46 Cytomegalovirus CMV 46 Chronic Myelogenous Leukemia CML 46 anti CD3 antibody 46 GBM tumors 46 type2 diabetes 46 embryonal rhabdomyosarcoma 46 malignant lymphoma 46 S. aureus isolates 46 autoantigens 46 validating biomarkers 46 CMV retinitis 46 lymphatic vasculature 46 breast endometrial 46 Lupus nephritis 46 P. gingivalis 46 lung epithelium 46 mechanistic studies 46 vascular disrupting agents 46 androgen receptor AR 46 Nephrogenic Systemic Fibrosis NSF 46 AA Amyloidosis 46 FVIIa 46 urothelial bladder cancer 46 epithelial cancers 46 rifamycins 46 bacterial enzyme 46 Fibrosis 46 waterborne microbes 46 skeletal fluorosis 46 spongiform encephalopathies 46 Genetic mutation 46 chromosomal instability 46 DVT PE 46 hematopoietic cancers 46 benign proliferative breast 46 Alzhemier 46 herpes infections 46 candidemia 46 colo rectal cancer 46 neuropsychiatric disorders 46 periodontal infections 46 carcinoid tumors 46 elevated triglyceride levels 46 TNF tumor necrosis 46 chronic lymphatic leukemia 46 carotid atherosclerosis 46 amyloid formation 46 microbial pathogenesis 46 Amyloidosis 46 thyroid deficiency 46 preclinically 46 zebrafish larvae 46 Alpha synuclein 46 primary biliary cirrhosis 46 untreated celiac disease 46 bacterial fungal 46 CRTC3 46 mycobacterium tuberculosis 46 HNSCC 46 myeloproliferative disorders 46 parasite Plasmodium 46 macrophage activation 46 carcinoid tumor 46 cutaneous lupus 46 DFTD 46 subcellular compartments 46 immunosuppressive medication 46 precancerous condition 46 dystrophy 46 TKI therapy 46 childhood leukemias 46 multiplex assay 46 β catenin 46 prostate carcinomas 46 ZNF# 46 B Cell Lymphoma 46 microbial biofilms 46 allogeneic HSCT 46 malperfusion 46 prostate tumor 46 lobular carcinoma 46 indolent NHL 46 blood coagulation disorders 46 GPIIb IIIa 46 IRX 2 46 allogeneic transplants 46 hereditary disorders 46 neural crest 46 pancreatic tumor 46 pre cancerous lesions 46 hematological diseases 46 Glioblastoma 46 lymphangiogenesis 46 intestinal inflammations 46 monoclonal antibody therapies 46 lumiliximab 46 multidrug resistant organisms 46 myasthenia gravis MG 46 seminoma 46 malaria parasite genome 46 cancerous tumors 46 Alzheimer pathology 46 lymphatic vessel 46 organogenesis 46 integrin activation 46 Zinc deficiency 46 bacteria fungi viruses 46 Periodontitis 46 hyperactivated 46 parasitic infection 46 dentinal hypersensitivity 46 inflammatory bowel diseases 46 tropical parasitic 46 glomerulonephritis 46 intravenous cyclophosphamide 46 metastatic cancer 46 Gleevec resistant 46 cardiac toxicity 46 EGFr 46 NTDDS 46 Genetic profiling 46 fibrosis 46 PDGF receptor 46 Cristofanilli 46 Genetic predisposition 46 mRNA decay 46 Schistosoma 46 GATA3 46 basal cell carcinoma BCC 46 retinal vein occlusion 46 cathepsins 46 Chronic Myeloid Leukemia CML 46 hepatobiliary 46 pemphigus vulgaris 46 trophic factors 46 olfactory dysfunction 46 vWF 46 artery hardening 46 TGF ß 46 intestinal infections 46 metastatic uveal melanoma 46 prostate adenocarcinoma 46 leukoencephalopathy PML 46 hedgehog signaling pathway 46 IL 1ß 46 PKCi 46 testosterone supplementation 46 immunological rejection 46 esophagitis 46 Nilotinib 46 metabolic abnormality 46 effector T 46 vWD 46 biowarfare pathogens 46 bacterial parasitic 46 peptide inhibitors 46 S. aureus infection 46 AAT deficiency 46 tumor 46 sleeping sickness 46 cardiometabolic syndrome 46 carcinogenesis